Apple Gets PTAB Wins On 2 Masimo Blood Oxygen Patents
The Patent Trial and Appeal Board has found that Apple has shown that most claims it challenged of two Masimo Corp. blood oxygen monitor patents are invalid, in the latest rulings...To view the full article, register now.
Already a subscriber? Click here to view full article